99
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy

, , &
Pages 297-302 | Published online: 10 Jun 2014

References

  • Immune Deficiency FoundationIDF Patient and Family Handbook. Chapter 1: The Immune System and Primary Immunodeficiency DiseasesTowson, MDImmune Deficiency Foundation2008 Available from: URL: http://www.primaryimmune.org/publications/book_pats/e_ch01.pdfAccessed March 22, 2014
  • BoyleJMBuckleyRHPopulation prevalence of diagnosed primary immunodeficiency diseases in the United StatesJ Clin Immunol200727549750217577648
  • JoshiAYIyerVNHaganJBSt SauverJLBoyceTGIncidence and temporal trends of primary immunodeficiency: a population-based cohort studyMayo Clin Proc2009841162219121249
  • WassermanRLManningSCDiagnosis and treatment of primary immunodeficiency disease: the role of the otolaryngologistAm J Otolaryngol201132432933720724030
  • ModellVGeeBLewisDBGlobal study of primary immunodeficiency diseases (PI) – diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell FoundationImmunol Res2011511617021935653
  • ConnollyMSimoensSKiovig for primary immunodeficiency: reduced infusion and decreased costs per infusionInt Immunopharmacol20111191358136121570491
  • DarbàJRestovicGKaskensLde AgustínTDirect medical costs of liquid intravenous immunoglobulins in children, adolescents, and adults in SpainJ Clin Pharmacol201252456657521593279
  • LucasMLeeMLortanJLopez-GranadosEMisbahSChapelHInfection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 yearsJ Allergy Clin Immunol2010125613541360. e420471071
  • HansenLGChangSHealth Research Data for the Real World: The MarketScan DatabasesTruven Health AnalyticsJuly, 2012
  • BloughDKRamseySDUsing generalized linear models to assess medical care costsHealth Serv Outcomes Res Methodol200012185202
  • FasthANyströmJQuality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulinJ Clin Immunol200828437037818256911